Clinical Trials Directory

Trials / Conditions / Demyelinating Autoimmune Diseases, CNS

Demyelinating Autoimmune Diseases, CNS

13 registered clinical trials studyying Demyelinating Autoimmune Diseases, CNS — 4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingInectolizumab With Steroid Optimization in Newly Treated NMOSD
NCT07159893
First Affiliated Hospital of Wenzhou Medical UniversityN/A
RecruitingNon-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS
NCT05834855
Amsterdam UMC, location VUmcPhase 3
CompletedUkulele Playing to Improve Cognition in People with Multiple Sclerosis: a Feasibility Study
NCT05792176
University of Texas at AustinN/A
RecruitingAcceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis
NCT04786821
Sheffield Teaching Hospitals NHS Foundation TrustN/A
Enrolling By InvitationLongitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders
NCT05982925
Icahn School of Medicine at Mount Sinai—
CompletedAerobic Exercise for Remyelination in Multiple Sclerosis
NCT04539002
Oregon Health and Science UniversityPhase 1 / Phase 2
CompletedHumoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab T
NCT04837651
Dragonfly Research, LLC—
UnknownPower Training in Older Multiple Sclerosis Patients
NCT04762342
University of AarhusN/A
UnknownA Registered Cohort Study of Inflammatory Demyelination Disease
NCT04386018
Ning Wang, MD., PhD.—
UnknownAutologous Stem/Stromal Cells in Neurological Disorders and Disease
NCT03297177
Regeneris MedicalN/A
UnknownEpigenetic Evaluation of HAT/HDAC Activity in PBMC From Patients With Clinically Isolated Syndrome
NCT02862301
Centre Hospitalier Universitaire de BesanconN/A
CompletedAutologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosi
NCT01056471
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y SaludPhase 1 / Phase 2
CompletedA Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)
NCT00304291
State University of New York at BuffaloPhase 4